EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Improving Clinical Outcomes Related to Preeclampsia: Real‐World Impacts of Implementation of a Redesigned Approach to Antenatal Care—The Initial Maternity Assessment and Planning ( IMAP ) Service

Ailsa Borbolla Foster iD, Harriet Calvert, Madeleine Hinwood, Caroline Kuhne, Jennifer Haxton, Nicole Bennett, Jon Hyett iD, Felicity Park

Australian and New Zealand Journal of Obstetrics and Gynaecology · 2026

DOI: 10.1111/ajo.70170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, 2026. Verfasst von Ailsa Borbolla Foster und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maternity and Gynaecology, John Hunter Hospital, New Lambton Hts, Australia. Hauptthemen laut MEDLINE: Pre-Eclampsia, Prenatal Care. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Preeclampsia is a major contributor to maternal and perinatal morbidity. First‐trimester predictive models for preterm preeclampsia have better efficacy than history‐based screening for prevention of this adverse pregnancy outcome. There are, however, few data describing implementation of this method of screening at a population level within public healthcare. Materials and Methods A retrospective service evaluation compared a historical cohort receiving standard maternity care and a contemporary cohort managed through the Initial Maternity Assessment and Planning (IMAP) service, a redesigned antenatal care approach focused on early multidisciplinary specialist maternity assessment and algorithm‐based preeclampsia screening prior to 14 weeks gestation. Singleton pregnancies within a metropolitan public hospital catchment were included. The primary outcome was preterm preeclampsia (leading to birth < 37 weeks). Secondary clinical outcomes included early‐onset preeclampsia (leading to birth < 32 weeks), severe maternal preterm preeclampsia, and rates of potential aspirin‐related obstetric complications. Secondary service outcomes included gestation at first visit and rates of early aspirin therapy for women at elevated risk.

Results

Historical and contemporary cohorts included 5 004 and 6 036 pregnancies, respectively. Median gestation at first visit decreased from 20 to 12 weeks. Analysis demonstrated a 49% reduction in the odds of preterm preeclampsia (0.91% to 0.60%; aOR 0.51, 95% CI 0.31–0.82) and a 59% reduction in the odds of severe preterm preeclampsia (0.38% to 0.20%; aOR 0.43, 95% CI 0.19–0.91). No significant differences were observed in early‐onset or term preeclampsia, fetal growth restriction, or complications related to antiplatelet therapy. The screen positive rate fell from 9.0% to 7.2%, while aspirin recommendation for high‐risk women increased from 23.9% to 77.8% overall and 98.2% in those receiving FMF screening.

Conclusion

A comprehensive, population‐based multidisciplinary first‐trimester assessment service, prioritizing FMF preeclampsia screening, can be successfully implemented within a public health setting and may be associated with lower odds of adverse clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaPrenatal CareHumansFemalePregnancyRetrospective StudiesAdultAspirinPregnancy OutcomeGestational AgePregnancy Trimester, FirstPlatelet Aggregation Inhibitors

Stichwörter der Autor:innen

Aspirin/therapeutic useHealth Services ImplementationMass Screening/methodsPreeclampsia/diagnosisPregnancy Outcome

Substanzen

AspirinPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Maternity and Gynaecology, John Hunter Hospital, New Lambton Hts, Australia.
  • University of Newcastle, School of Medicine and Public Health, Callaghan, New South Wales, Australia.
  • Biostatistics Unit, Hunter Medical Research Institute (HMRI), Newcastle, New South Wales, Australia.
  • Ingham Institute, Faculty of Medicine, Western Sydney University, Liverpool, New South Wales, Australia.
  • Department of Obstetrics and Gynaecology, Liverpool Hospital, Liverpool, New South Wales, Australia.

ORCID-Profile: Ailsa Borbolla Foster, Jon Hyett

Zitieren

APA

Borbolla Foster, A., Calvert, H., Hinwood, M., Kuhne, C., Haxton, J., Bennett, N., Hyett, J., & Park, F. (2026). Improving Clinical Outcomes Related to Preeclampsia: Real‐World Impacts of Implementation of a Redesigned Approach to Antenatal Care—The Initial Maternity Assessment and Planning ( IMAP ) Service. Australian and New Zealand Journal of Obstetrics and Gynaecology. https://doi.org/10.1111/ajo.70170

Vancouver

Borbolla Foster A, Calvert H, Hinwood M, Kuhne C, Haxton J, Bennett N, et al. Improving Clinical Outcomes Related to Preeclampsia: Real‐World Impacts of Implementation of a Redesigned Approach to Antenatal Care—The Initial Maternity Assessment and Planning ( IMAP ) Service. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2026. doi:10.1111/ajo.70170

BibTeX
@article{BorbollaFoster2026,
  author = {Borbolla Foster, Ailsa and Calvert, Harriet and Hinwood, Madeleine and Kuhne, Caroline and Haxton, Jennifer and Bennett, Nicole and Hyett, Jon and Park, Felicity},
  title = {Improving Clinical Outcomes Related to Preeclampsia: Real‐World Impacts of Implementation of a Redesigned Approach to Antenatal Care—The Initial Maternity Assessment and Planning ( IMAP ) Service},
  journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
  year = {2026},
  doi = {10.1111/ajo.70170}
}
Kostenlos starten →